Conduit Pharmaceuticals Inc (NASDAQ: CDT) – Not A Clear Buying Opportunity?
Conduit Pharmaceuticals Inc (CDT) concluded trading on Wednesday at a closing price of $0.78, with 3.37 million shares of worth about $2.63 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -92.82% during that period and on April 16, 2025 the price saw a […]
Is Conduit Pharmaceuticals Inc (NASDAQ: CDT) Proving The Doubters Wrong?
Conduit Pharmaceuticals Inc (CDT) concluded trading on Thursday at a closing price of $1.07, with 70.82 million shares of worth about $75.78 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -89.95% during that period and on April 10, 2025 the price saw a […]
Conduit Pharmaceuticals Inc (NASDAQ: CDT) – Suitable For Long Term Buy?
Currently, there are 4.71M common shares owned by the public and among those 3.31M shares have been available to trade. Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, […]
